【摘 要】
：
LAT1 overexpressed on membrane of various tumor cells, are potential targets for tumor-targeting therapy.This study aimed to develop a LAT1-mediated drug delivery to target chemotherapeutic agents to
【机 构】
：
State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmace
【出 处】
：
2015年第一届药代动力学朝阳论坛
论文部分内容阅读
LAT1 overexpressed on membrane of various tumor cells, are potential targets for tumor-targeting therapy.This study aimed to develop a LAT1-mediated drug delivery to target chemotherapeutic agents to LAT1-overexpressed tumor cells in vitro and in vivo.Here, different amino acids were attached to the N-terminal of DOX via the amido bond.After screening with S2-LAT1 model, the molecular Asp-DOX with a free carboxyl and a free amino group on the α-carbon atom of the Asp residue was an efficient compound.The product Asp-DOX was characterized by HPLC spectroscopy and mass spectrometry.In vitro, the Asp-DOX exerted stronger inhibition to the cancer cells (HepG2, HCT116 and MCF7) overexpressing LAT1 and the uptake of Asp-DOX was about 3.5-fold higher than that of DOX in HepG2 cells.Data of pharmacokinetics showed that Asp-DOX expressed a longer circulation time (t1/2 =49.14 min) in the blood compared to DOX (t1/2=19.12 min).
其他文献
Many furan-containing compounds have been reported to be toxic and/or carcinogenic.Furanoids occur in a wide range of fruits, herbs, foods, and beverages.The demand to identify harmful furans potentia
Diosbulbin B (DIOB) is the most abundant component of Dioscorea bulbifera L.(DB), a traditional Chinese medicine herb.DIOB and DB extracts have been reported to cause liver injury in animals.The mecha
Human carboxylesterase 1 (hCE-1) are a representative B-esterase, involved in the hydrolysis of many endogenous and exogenous compounds and are thus responsible for the activation of many prodrugs.Dys
Tanshinol has desirable antianginal and pharmacokinetic properties and is a key compound of Salvia miltiorrhiza roots (Danshen).The reported effective concentrations of tanshinol in vitro are higher (
Fast metabolism is one of key issues for many drug candidates, which could result in poor bioavailability, short half-life and significant drug-drug interactions.To identify the issue in early phase o
CPRC1 is a novel investigated proton pump inhibitor, which shows dramaticsuccess in the management of acid-related disorders.Now this drug is being developed in Phase Ⅱ study in China.In this paper fo
Drug ADME experiment in humans is a pivotal drug metabolism study in support of drug development and registration.Human ADME study provides information on the exposure of drug related components, excr
There are extensive reports on drug-metabolizing enzymes dysregulation in inflammatory diseases and the distinct regulatory effects of different cvtokines.The present study aimed to depict the changes
Trastuzumab Emtansine(T-DM1, KadcylaTM, Genentech Inc.) is an antibody-drug conjugate(ADC) that received US FDA approval in 2013 for the treatment of human epidermal growth factor receptor 2 (HER2)-po
Herbal medicinal products belong to a main part of complementary and alternative medicine and have worldwide using integrated with conventional medicines for treatment.However, the increasing risk of